Bill Sponsor
House Bill 171
118th Congress(2023-2024)
HALT Fentanyl Act
Introduced
Introduced
Introduced in House on Jan 9, 2023
Overview
Text
Introduced
Jan 9, 2023
Latest Action
Jan 20, 2023
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
171
Congress
118
Policy Area
Crime and Law Enforcement
Crime and Law Enforcement
Primary focus of measure is criminal offenses, investigation and prosecution, procedure and sentencing; corrections and imprisonment; juvenile crime; law enforcement administration. Measures concerning terrorism may fall under Emergency Management or International Affairs policy areas.
Sponsorship by Party
Republican
Virginia
Republican
Minnesota
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act

This bill places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.

Additionally, the bill establishes a new, alternative registration process for schedule I research that is funded by the Department of Health and Human Services or the Department of Veterans Affairs or that is conducted under an investigative new drug exemption from the Food and Drug Administration.

The bill also makes several other changes to registration requirements for conducting research with controlled substances, including

  • permitting a single registration for related research sites in certain circumstances,
  • waiving the requirement for a new inspection in certain situations, and
  • allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.
Text (1)
January 9, 2023
Actions (3)
01/20/2023
Referred to the Subcommittee on Health.
01/09/2023
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
01/09/2023
Introduced in House
Public Record
Record Updated
Mar 18, 2024 3:06:26 PM